PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $476,526 | -72.6% | 57,069 | -56.4% | 0.00% | 0.0% |
Q2 2023 | $1,741,555 | +519.8% | 130,944 | +170.5% | 0.00% | -50.0% |
Q3 2022 | $281,000 | +31.3% | 48,405 | -0.7% | 0.00% | +33.3% |
Q2 2022 | $214,000 | -51.0% | 48,744 | +1.4% | 0.00% | -40.0% |
Q1 2022 | $437,000 | -58.1% | 48,057 | -5.8% | 0.01% | -50.0% |
Q4 2021 | $1,043,000 | -39.2% | 50,989 | -24.0% | 0.01% | -56.5% |
Q3 2021 | $1,715,000 | -26.6% | 67,107 | +0.4% | 0.02% | -30.3% |
Q2 2021 | $2,338,000 | +5.8% | 66,857 | +0.8% | 0.03% | -5.7% |
Q1 2021 | $2,210,000 | +599.4% | 66,333 | +107.3% | 0.04% | +483.3% |
Q3 2020 | $316,000 | – | 32,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |